Author Correction: Chronic kidney disease (Nature Reviews Disease Primers, (2025), 11, 1, (8), 10.1038/s41572-024-00589-9)

Paola Romagnani; Rajiv Agarwal; Juliana C.N. Chan; Adeera Levin; Robert Kalyesubula; Sabine Karam; Masaomi Nangaku; Bernardo Rodríguez-Iturbe; Hans Joachim Anders

doi:10.1038/s41572-025-00641-2

Author Correction: Chronic kidney disease (Nature Reviews Disease Primers, (2025), 11, 1, (8), 10.1038/s41572-024-00589-9)

Paola Romagnani
, Rajiv Agarwal
, Juliana C.N. Chan
, Adeera Levin
, Robert Kalyesubula
, Sabine Karam
, Masaomi Nangaku
, Bernardo Rodríguez-Iturbe
, Hans Joachim Anders

Medicine - Renal and Hypertension Division

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Nature Reviews Disease Primershttps://doi.org/10.1038/s41572-024-00589-9, published online 30 January 2025. In the version of this article initially published, in the “Correction of abnormal calcium–phosphate metabolism” section, there was an error in the sentence now reading “An oral small molecule, tenapanor, has been approved in the USA, Japan and China…” where incorrect country names were originally listed. The countries and accompanying reference citations have now been updated in the HTML and PDF versions of the article.

Original language	English (US)
Article number	53
Journal	Nature Reviews Disease Primers
Volume	11
Issue number	1
DOIs	https://doi.org/10.1038/s41572-025-00641-2
State	Published - Dec 2025

Bibliographical note

Publisher Copyright:
© Springer Nature Limited 2025.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

PubMed: MeSH publication types

Published Erratum

Publisher link

10.1038/s41572-025-00641-2

Find It

Find It at U of M Libraries

Cite this

@article{f042f664cfef448590051f10f52348c6,

title = "Author Correction: Chronic kidney disease (Nature Reviews Disease Primers, (2025), 11, 1, (8), 10.1038/s41572-024-00589-9)",

abstract = "Correction to: Nature Reviews Disease Primershttps://doi.org/10.1038/s41572-024-00589-9, published online 30 January 2025. In the version of this article initially published, in the {\textquotedblleft}Correction of abnormal calcium{\textendash}phosphate metabolism{\textquotedblright} section, there was an error in the sentence now reading {\textquotedblleft}An oral small molecule, tenapanor, has been approved in the USA, Japan and China…{\textquotedblright} where incorrect country names were originally listed. The countries and accompanying reference citations have now been updated in the HTML and PDF versions of the article.",

author = "Paola Romagnani and Rajiv Agarwal and Chan, \{Juliana C.N.\} and Adeera Levin and Robert Kalyesubula and Sabine Karam and Masaomi Nangaku and Bernardo Rodr{\'i}guez-Iturbe and Anders, \{Hans Joachim\}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Limited 2025.",

year = "2025",

month = dec,

doi = "10.1038/s41572-025-00641-2",

language = "English (US)",

volume = "11",

journal = "Nature Reviews Disease Primers",

issn = "2056-676X",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Author Correction

T2 - Chronic kidney disease (Nature Reviews Disease Primers, (2025), 11, 1, (8), 10.1038/s41572-024-00589-9)

AU - Romagnani, Paola

AU - Agarwal, Rajiv

AU - Chan, Juliana C.N.

AU - Levin, Adeera

AU - Kalyesubula, Robert

AU - Karam, Sabine

AU - Nangaku, Masaomi

AU - Rodríguez-Iturbe, Bernardo

AU - Anders, Hans Joachim

PY - 2025/12

Y1 - 2025/12

N2 - Correction to: Nature Reviews Disease Primershttps://doi.org/10.1038/s41572-024-00589-9, published online 30 January 2025. In the version of this article initially published, in the “Correction of abnormal calcium–phosphate metabolism” section, there was an error in the sentence now reading “An oral small molecule, tenapanor, has been approved in the USA, Japan and China…” where incorrect country names were originally listed. The countries and accompanying reference citations have now been updated in the HTML and PDF versions of the article.

AB - Correction to: Nature Reviews Disease Primershttps://doi.org/10.1038/s41572-024-00589-9, published online 30 January 2025. In the version of this article initially published, in the “Correction of abnormal calcium–phosphate metabolism” section, there was an error in the sentence now reading “An oral small molecule, tenapanor, has been approved in the USA, Japan and China…” where incorrect country names were originally listed. The countries and accompanying reference citations have now been updated in the HTML and PDF versions of the article.

UR - https://www.scopus.com/pages/publications/105012158409

UR - https://www.scopus.com/pages/publications/105012158409#tab=citedBy

U2 - 10.1038/s41572-025-00641-2

DO - 10.1038/s41572-025-00641-2

M3 - Comment/debate

C2 - 40691448

AN - SCOPUS:105012158409

SN - 2056-676X

VL - 11

JO - Nature Reviews Disease Primers

JF - Nature Reviews Disease Primers

IS - 1

M1 - 53

ER -

Author Correction: Chronic kidney disease (Nature Reviews Disease Primers, (2025), 11, 1, (8), 10.1038/s41572-024-00589-9)

Abstract

Bibliographical note

UN SDGs

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Fingerprint

Cite this